Shearman & Sterling advised the underwriters in connection with the follow-on public offering by Inspire Medical Systems, Inc. and certain selling stockholders of 2,875,000 shares of common stock at a public offering price of $40.00 per share, resulting in combined aggregate gross proceeds to Inspire and the selling stockholders of approximately $115 million. The offering consisted of 1,875,000 shares sold by Inspire, including 375,000 shares sold pursuant to the exercise in full of the option to purchase additional shares granted to the underwriters by Inspire in connection with the offering, and 1,000,000 shares sold by certain of Inspire’s stockholders.

Inspire Medical Systems, Inc. is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. The company’s proprietary Inspire system is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

The Team